Elizaveta A. Berestova

Elizaveta A. Berestova

Auto-generated profile, based on publicly available information

Elizaveta A. Berestova

Research Center of Neurology

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 June 2023 in Consilium Medicum
Verified
Journal Article
Open access
PDF file
ESEkaterina S. Schelkanovtseva
Ekaterina S. Schelkanovtseva
OMOlga Iu. Mironova
Olga Iu. Mironova
KSKirill A. Solovev
Kirill A. Solovev
EBElizaveta A. Berestova
Elizaveta A. Berestova
ABAlexander A. Balakhonov
Alexander A. Balakhonov
БАБалахонов Александр Алексеевич
Балахонов Александр Алексеевич
Background. The identification of early predictors of poor outcomes of new coronavirus infection is necessary for optimizing patient management algorithms for hospitalized patients with COVID-19. Aim. To study the role of chitotriosidase activity as a marker of unfavorable outcomes in COVID-19 hospitalized patients. Materials and methods. The prospective observational single-center study included 347 patients with COVID-19 hospitalized in university clinic. In addition to the standard laboratory analysis (complete blood count, C-reactive protein, ferritin, creatinine, international normalized ratio, etc.) the blood serum chitotriosidase activity was determined at all the patients on admission. Primary endpoints were mortality from all causes and performing invasive ventilation (IV) and/or non-invasive ventilation (NIV). This study was approved by the Local Ethics Committee №12-21 (Clinical Trial Registry: NCT04752085). Results. A total of 347 patients were enrolled in this study (average age 66 years, females 182 52.5%), 30 patients (8.6%) died during the hospitalization, 39 (11.2%) performed IV or NIV. Along with age more than 65 (odds ratio OR 10.81, 95% confidence interval CI 2.6444.22) and Neutrophil-Lymphocyte Ratio higher than 7 (OR 15.89, 95% CI 3.0981.65) chitotriosidase activity higher than 170 ng/hr/ml (OR 4.23, 95% CI 1.4512.35) were independent predictors of mortality during hospitalization. Neutrophil-Lymphocyte Ratio higher than 5.6 (OR 11.22, 95% CI 2.3753,1) and сhitotriosidase activity higher than 151 ng/hr/ml (OR 3.17, 95% CI 1.317.67) have been evaluated as predictors of performing IV/NIV. Conclusion. Chitotriosidase level more than 151 nmol/h/mL could be considered as an early predictor of severity and poor prognosis in hospitalized patients with COVID-19.

3 August 2026 in Epilepsy and paroxysmal conditions
Verified
Journal Article
Open access
PDF file
MMMarina Maksimova
Marina Maksimova
ABA. G. Broutian
A. G. Broutian
EBE. A. Berestova
E. A. Berestova
Focal epilepsy is associated with prominent autonomic disturbances occurring during the ictal, postictal, and interictal periods. Differential assessment of such disorders is important for improving the effectiveness of antiseizure therapy and reducing the risk of sudden unexpected death in epilepsy (SUDEP). The review summarizes current concepts regarding the pathophysiological mechanisms, clinical semiology, and diagnostic significance of autonomic manifestations in patients with focal epilepsy. During the ictal period, the most commonly observed abnormalities include changes in heart rhythm (tachycardia and, less commonly, bradycardia), respiratory disturbances (apnea and hyperventilation), gastrointestinal symptoms (epigastric aura), and pilomotor reactions. Postictal autonomic disturbances include arterial hypotension, hypersalivation, aspiration phenomena, and postictal arrhythmia, all of which correlate with SUDEP risk. Interictal disturbances are characterized by reduced heart rate variability, arterial hypertension, neurogenic bladder dysfunction, and thermoregulatory disorders, reflecting suppression of autonomic nervous system activity. Autonomic disturbances in focal epilepsy represent clinically significant phenomena that nevertheless are often inadequately assessed in routine clinical practice. Detailed analysis of these disorders may help refine epileptogenic zone localization, improve risk stratification for life-threatening conditions, and contribute to a more personalized therapeutic approach.

31 August 2023 in Siberian Journal of Clinical and Experimental Medicine
Verified
Journal Article
Open access
PDF file
ESE. S. Shchelkanovtseva
E. S. Shchelkanovtseva
OMO. Yu. Mironova
O. Yu. Mironova
КСК. А. Соловьёв
К. А. Соловьёв
EBE. A. Berestova
E. A. Berestova
ABA. A. Balakhonov
A. A. Balakhonov
APA. S. Panferov
A. S. Panferov
Aim: To assess the relationship between initial plasma chitotriosidase (CHIT) activity and the dynamics of computed tomography (CT) data: lung injury volume, liver and spleen density in COVID-19 hospitalized patients.Material and Methods. The sub-analysis of the study registered in the Clinical Trial Registry with number: NCT04752085 was performed. The data of patients with available CT data of the chest on admission and at least once in dynamics during the period of hospitalization and the initial level of CTS in the blood plasma were analyzed. The density of the liver and spleen was determined in the scanned upper abdominal images, followed by the calculation of the ratio of the density of the liver to the density of the spleen.Results. A total of 121 patients were enrolled in this sub-analysis. Their baseline characteristics were as follows: median age 62 [53;70], males 48,7%. Between the day of admission and 7 [6;9] days of hospitalization, there was a significant increase in mean liver density from 52,04 [45,4; 56,7] to 57,5 [49,8; 62,7] HU and L/S ratio (liver to spleen ratio) 1,05 [0,91; 1,14] to 1,13 [0,99; 1,28], p < 0,001. The dynamics of the volume of lung tissue damage was multidirectional and, in general, did not change significantly. CHIT activity among patients whose lung injury volume increased during the hospitalization was significantly lower (65 [27; 119] nmol/ml/h) compared with patients whose lung injury volume did not change or decreased (124 [53; 232] nmol/ml/h), p = 0.006. The risk of lung injury progression was higher in patients with baseline CHIT level less than 100 nmol/h/ mL, (HR 3.1, 95% CI 1.4–6.9).Conclusion. Insufficient increase of CHIT activity can be associated with progression of lung injury, but does not affect the evolution of liver and spleen density as measured by CT.